Dabigatran, warfarin ranked top for risk in 2011

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1406, 2012-01, pp. : 1-1

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dabigatran etexilate: a winner vs warfarin in the UK context

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 641, 2011-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Pharmacogenetics of antiplatelets and anticoagulants: a report on clopidogrel, warfarin and dabigatran

By Ross Stephanie   Paré Guillaume  

Pharmacogenomics, Vol. 14, Iss. 13, 2013-10 ,pp. : 1565-1572

Future Medicine

Access to resources Recommend Favorite

Dabigatran bleeding risk warning issued in Japan

By  

Reactions Weekly, Vol. 1, Iss. 1367, 2011-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Danish data highlight bleeding risk with dabigatran etexilate

By  

Reactions Weekly, Vol. 1, Iss. 1408, 2012-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Dabigatran etexilate: Thrombus formation after switching from warfarin in an elderly patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1394, 2012-01 ,pp. : 17-18

Adis International

Access to resources Recommend Favorite